Wall Street Zen downgraded shares of Turtle Beach (NASDAQ:TBCH – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday,Wall Street Zen reports. A number of other brokerages have also recently issued reports on TBCH. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Turtle Beach […]

Wall Street Zen downgraded shares of Lightwave Logic (NASDAQ:LWLG – Free Report) from a sell rating to a strong sell rating in a research report released on Sunday,Wall Street Zen reports. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Lightwave Logic in a report on Friday, July 17th. One analyst has rated […]

Wall Street Zen cut shares of Columbia Sportswear (NASDAQ:COLM – Free Report) from a strong-buy rating to a buy rating in a report released on Saturday,Wall Street Zen reports. COLM has been the subject of a number of other research reports. Zacks Research lowered shares of Columbia Sportswear from a “strong-buy” rating to a “hold” […]

Wall Street Zen downgraded shares of AlTi Global (NASDAQ:ALTI – Free Report) from a hold rating to a sell rating in a report issued on Saturday,Wall Street Zen reports. ALTI has been the subject of several other reports. Weiss Ratings restated a “sell (d-)” rating on shares of AlTi Global in a research report on […]

Wall Street Zen lowered shares of Rivian Automotive (NASDAQ:RIVN – Free Report) from a hold rating to a sell rating in a research report report published on Saturday morning,Wall Street Zen reports. Other equities research analysts also recently issued reports about the company. DA Davidson increased their price target on Rivian Automotive from $14.00 to […]

Wall Street Zen downgraded shares of MakeMyTrip (NASDAQ:MMYT – Free Report) from a hold rating to a sell rating in a research note published on Saturday. Several other equities research analysts also recently commented on MMYT. The Goldman Sachs Group set a $84.00 price objective on shares of MakeMyTrip in a research note on Saturday, […]

Wall Street Zen lowered shares of Bluejay Diagnostics (NASDAQ:BJDX – Free Report) from a hold rating to a sell rating in a research note released on Saturday morning. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Bluejay Diagnostics in a research note on Wednesday, June 24th. One investment analyst has rated the […]

Wall Street Zen cut shares of E.W. Scripps (NASDAQ:SSP – Free Report) from a hold rating to a sell rating in a report published on Saturday morning. A number of other analysts have also weighed in on the stock. Wells Fargo & Company reduced their price target on shares of E.W. Scripps from $4.70 to […]

Wall Street Zen cut shares of Viavi Solutions (NASDAQ:VIAV – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Saturday. Other equities research analysts also recently issued research reports about the stock. UBS Group reduced their target price on shares of Viavi Solutions from $60.00 to […]

Wall Street Zen downgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research note issued to investors on Saturday. Other equities analysts have also issued research reports about the stock. Truist Financial set a $93.00 target price on shares of DexCom and gave the company a […]

Wall Street Zen downgraded shares of Landstar System (NASDAQ:LSTR – Free Report) from a buy rating to a hold rating in a research note published on Saturday morning. A number of other brokerages have also commented on LSTR. UBS Group reiterated a “neutral” rating and issued a $195.00 price objective on shares of Landstar System […]

Wall Street Zen cut shares of Akanda (NASDAQ:AKAN – Free Report) from a sell rating to a strong sell rating in a research note released on Saturday. Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Akanda in a report on Thursday, August 13th. One research analyst has rated the stock with a […]

Wall Street Zen cut shares of NovoCure (NASDAQ:NVCR – Free Report) from a buy rating to a hold rating in a research report report published on Saturday morning. Other equities research analysts also recently issued research reports about the company. Zacks Research upgraded NovoCure from a “strong sell” rating to a “hold” rating in a […]